EVISA Glossary on | Contact EVISA | Sitemap | Home   
Search
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:
Chemocare: Cisplatin

Link http://chemocare.com/chemotherapy/drug-info/cispla
tin.aspx
Elements Platinum
Species Complex
Topic Information - Pharmacy/Pharmacology
Owner Company
Location ----
Language English
Description
Cisplatin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug.  Cisplatin is classified as an "alkylating agent."   (For more detail, see "How Cisplatin Works" section below).





Events
See the complete list of deadlines!
73rd ASMS Conference on Mass Spectrometry
01.06.2025
Baltimore Convention Center, Baltimore, Maryland
BERM 16: 16th International Symposium on Biological and Environmental Reference Materials
01.06.2025
Halifax Convention Centre | Halifax, Nova Scotia, Canada
NAWLA'25: 5th North American Workshop on Laser Ablation
03.06.2025
The University of Tennessee, Knoxville
... more Events
News
What's new on EVISA's web site ?
Speciation analysis in routine applications
Speciation Analysis – A Key Focus in Analytical Chemistry
Speciation analysis of lead in seafood using short-column ion chromatography coupled with ICP-MS
Selenium, Mercury, and Health Benefit Values of Ocean Fish of the Central North Pacific
... more News




Imprint     Disclaimer

© 2003 - 2025 by European Virtual Institute for Speciation Analysis ( EVISA )